首页/数据集/Demographic, CSF and clinical data at sampling and follow-up.

Demographic, CSF and clinical data at sampling and follow-up.

NIAID Data Ecosystem2026-03-10 收录

神经退行性疾病生物标志物

临床随访

数据链接：

https://figshare.com/articles/dataset/Demographic_CSF_and_clinical_data_at_sampling_and_follow-up_/5278423 数据链接链接失效反馈

官方服务：

资源简介：

Demographic, CSF and clinical data at sampling and follow-up.

应用场景：

创建时间：

2017-08-05

神经退行性疾病生物标志物

脂质组学

Background: Alzheimer’s disease (AD) cannot currently be diagnosed by a blood test. One reason may be gender differences. Another may be the statistical methods used. The authors evaluate these possib

NIAID Data Ecosystem20

Data_Sheet_1_The Quest for Anti-α-Synuclein Antibody Specificity—Lessons Learnt From Flow Cytometry Analysis.PDF

α-突触核蛋白抗体

神经退行性疾病生物标志物

The accumulation of alpha-synuclein (aSyn) is the hallmark of a group of neurodegenerative conditions termed synucleopathies. Physiological functions of aSyn, including those outside of the CNS, remai

NIAID Data Ecosystem10

Alzheimer's Oral and Gut Microbiome Vancouver Canada

阿尔茨海默病微生物组

神经退行性疾病生物标志物

A study of the oral and gut microbiome in a human cohort of Alzheimer's disease and matched controls from Vancouver, Canada

NIAID Data Ecosystem10

First AIDS event or death by treatment strategy and by follow-up time.

艾滋病治疗评估

临床随访

*Test for heterogeneity.

NIAID Data Ecosystem10

Proteomics Analysis Reveals Novel Components in the Detergent-Insoluble Subproteome in Alzheimer’s Disease

阿尔茨海默病蛋白质组学

神经退行性疾病生物标志物

Neurodegenerative diseases are often defined pathologically by the presence of protein aggregates. These aggregates, including amyloid plaques in Alzheimer’s disease (AD), result from the abnormal acc

NIAID Data Ecosystem10

Demographic, CSF and clinical data at sampling and follow-up.

资源简介：

相关数据集